PlainRecalls
FDA Drug Low Class III Terminated

APLENZIN¿ (bupropion hydrobromide), extended-release tablets, 174 mg, 7-count HDPE bottle, Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7, NDC 0024-5810-07.

Reported: November 5, 2014 Initiated: June 5, 2014 #D-0051-2015

Product Description

APLENZIN¿ (bupropion hydrobromide), extended-release tablets, 174 mg, 7-count HDPE bottle, Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7, NDC 0024-5810-07.

Reason for Recall

Labeling: Incorrect or Missing Package Insert

Details

Units Affected
20,499 HDPE bottles
Distribution
Nationwide
Location
Bridgewater, NJ

Frequently Asked Questions

What product was recalled?
APLENZIN¿ (bupropion hydrobromide), extended-release tablets, 174 mg, 7-count HDPE bottle, Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7, NDC 0024-5810-07.. Recalled by Valeant Pharmaceuticals North America LLC. Units affected: 20,499 HDPE bottles.
Why was this product recalled?
Labeling: Incorrect or Missing Package Insert
Which agency issued this recall?
This recall was issued by the FDA Drug on November 5, 2014. Severity: Low. Recall number: D-0051-2015.